Profil
Dr Colas studied molecular biology at the University of Lyon and At the end of 1993, he joined the laboratory of Roger Brent, at the Department of Molecular Biology of Massachusetts General Hospital (Harvard Medical School, Boston, USA), where he contributed to the development of the peptide aptamer technology.
Dr Colas was recruited by the INSERM and came back to Lyon in 1998 to join Dr Rudkin's lab.
He pursued his work on peptide aptamer technologies.
In 2002, Dr Colas took a leave from the INSERM to become Scientific Director of Aptanomics.
Ehemalige bekannte Positionen von Pierre Colas
| Unternehmen | Position | Ende |
|---|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 24.01.2008 |
Ausbildung von Pierre Colas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Ecole Centrale Lyon
Ecole Centrale Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Normale Supérieure de Lyon
École Normale Supérieure de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















